BACKGROUND: Neurosurgical resection is considered the standard treatment for most patients with a single brain metastasis. However, radiosurgery (RS) is a reasonable alternative. It was demonstrated that whole-brain radiotherapy (WBRT) in addition to RS improves local control of 1-3 brain metastases. Little information is available regarding WBRT in addition to RS for a single lesion. METHODS: Data of 63 patients who received RS alone for a single brain metastasis were retrospectively compared with 39 patients treated with WBRT+RS for local control of the treated metastasis, distant intracerebral control, and survival. Seven additional potential prognostic factors were investigated including age, sex, Karnofsky performance score, tumor type, extracerebral metastases, recursive partitioning analysis (RPA) class, and interval from tumor diagnosis to irradiation. RESULTS: The 1-year local control rates were 49% after RS and 77% after WBRT+RS (P = .040). The 1-year distant control rates were 70% and 90%, respectively (P = .08). The 1-year survival rates were 57% and 61%, respectively (P = .47). On multivariate analysis, improved local control was associated with WBRT+RS (risk ratio [RR], 1.95; P = .033) and interval from tumor diagnosis to irradiation >15 months (RR, 1.88; P = .042). Improved distant control was almost associated with WBRT+RS (RR, 2.24; P = .05) and age (RR, 2.20; P = .05). Improved survival was associated with KPS 90-100 (RR, 1.73; P = .040), no extracerebral metastases (RR, 1.88; P = .013), RPA class 1 (RR, 2.06; P = .005), and interval from tumor diagnosis to irradiation >15 months (RR, 1.98; P = .009). CONCLUSION: The addition of WBRT to RS was associated with improved local control and distant intracerebral control but not survival.
BACKGROUND: Neurosurgical resection is considered the standard treatment for most patients with a single brain metastasis. However, radiosurgery (RS) is a reasonable alternative. It was demonstrated that whole-brain radiotherapy (WBRT) in addition to RS improves local control of 1-3 brain metastases. Little information is available regarding WBRT in addition to RS for a single lesion. METHODS: Data of 63 patients who received RS alone for a single brain metastasis were retrospectively compared with 39 patients treated with WBRT+RS for local control of the treated metastasis, distant intracerebral control, and survival. Seven additional potential prognostic factors were investigated including age, sex, Karnofsky performance score, tumor type, extracerebral metastases, recursive partitioning analysis (RPA) class, and interval from tumor diagnosis to irradiation. RESULTS: The 1-year local control rates were 49% after RS and 77% after WBRT+RS (P = .040). The 1-year distant control rates were 70% and 90%, respectively (P = .08). The 1-year survival rates were 57% and 61%, respectively (P = .47). On multivariate analysis, improved local control was associated with WBRT+RS (risk ratio [RR], 1.95; P = .033) and interval from tumor diagnosis to irradiation >15 months (RR, 1.88; P = .042). Improved distant control was almost associated with WBRT+RS (RR, 2.24; P = .05) and age (RR, 2.20; P = .05). Improved survival was associated with KPS 90-100 (RR, 1.73; P = .040), no extracerebral metastases (RR, 1.88; P = .013), RPA class 1 (RR, 2.06; P = .005), and interval from tumor diagnosis to irradiation >15 months (RR, 1.98; P = .009). CONCLUSION: The addition of WBRT to RS was associated with improved local control and distant intracerebral control but not survival.
Authors: Kaisorn L Chaichana; Shekhar Gadkaree; Karthik Rao; Thomas Link; Daniele Rigamonti; Michael Purtell; Ilene Browner; Jon Weingart; Alessandro Olivi; Gary Gallia; Chetan Bettegowda; Henry Brem; Michael Lim; Alfredo Quinones-Hinojosa Journal: Neurol Res Date: 2013-08-16 Impact factor: 2.448
Authors: Diana Steinmann; Bettina Maertens; Stefan Janssen; Martin Werner; Jörg Frühauf; Makoto Nakamura; Hans Christiansen; Michael Bremer Journal: J Cancer Res Clin Oncol Date: 2012-04-24 Impact factor: 4.553
Authors: Betul Berber; Rafael Ibarra; Laura Snyder; Min Yao; Jeffrey Fabien; Michael T Milano; Alan W Katz; Karyn Goodman; Kevin Stephans; Galal El-Gazzaz; Federico Aucejo; Charles Miller; John Fung; Simon Lo; Mitchell Machtay; Juan Sanabria Journal: HPB (Oxford) Date: 2013-01-14 Impact factor: 3.647
Authors: Aaron E Wagner; Andy Chen; Christopher J Anker; Jonathan D Tward; Amol J Ghia; Randy L Jensen; Dennis C Shrieve Journal: J Radiosurg SBRT Date: 2014
Authors: Sandro M Krieg; Thomas Picht; Nico Sollmann; Ina Bährend; Florian Ringel; Srikantan S Nagarajan; Bernhard Meyer; Phiroz E Tarapore Journal: Front Oncol Date: 2016-12-21 Impact factor: 6.244
Authors: Bettina Märtens; Stefan Janssen; Martin Werner; Jörg Frühauf; Hans Christiansen; Michael Bremer; Diana Steinmann Journal: BMC Cancer Date: 2012-10-25 Impact factor: 4.430
Authors: Thomas Obermueller; Michael Schaeffner; Julia Gerhardt; Bernhard Meyer; Florian Ringel; Sandro M Krieg Journal: BMC Cancer Date: 2014-01-14 Impact factor: 4.430